Product logins

Find logins to all Clarivate products below.


Dr Dilpreet Singh MD Ortho

Partner & Head JAPAC Consulting, Clarivate Consulting Services

Dr. Dilpreet Singh, is an experienced life sciences consultant with over 20 years in pharma & biotech. A surgeon turned management consultant turned entrepreneur and back to consulting, he has breadth of experience across the pharma & life sciences segments including operations & strategy execution.

Dilpreet was a Sr. Principal at L.E.K. Consulting and IQVIA (earlier IMS Health), leading the consulting practice across the SEA and APAC region. He has been a trusted advisor to clients across Market access & Go-to-market strategies, product and portfolio lifecycle management from R&D investments to licensing or launch, along with corporate strategies such as M&A, divestment and partnerships. He also has industry experience, most recently at Cerecin, being the COO of the neuro focused biotech with P3 asset in Alzheimer’s Disease and also at Johnson & Johnson earlier.

He has also been a speaker at industry leading events (eg APACMed, ESMO Asia etc), with published thought leadership across new and emerging technologies, and commercial models in biopharma and medical devices space

Dilpreet is passionate about technology in life sciences and founded Juvoxa, a health-tech patient-centric care platform to drive evidence driven outcomes in specialty care. He is actively involved in startup ecosystem in the region, and is an active investor, mentor and advisor to some promising early-stage startups in the region as well.

Dilpreet holds an MBA from the Indian School of Business, Hyderabad and Masters in Surgery (Orthopedics) from All India Institute of Medical Sciences, Delhi

Related resources

生物制药领域中隐藏于公开信息中的竞争信号 生物制药领域中隐藏于公开信息中的竞争信号
Blog June 24, 2026
生物制药领域中隐藏于公开信息中的竞争信号
在生命科学领域部署代理式 AI 的五大经验教训 在生命科学领域部署代理式 AI 的五大经验教训
Blog June 16, 2026
在生命科学领域部署代理式 AI 的五大经验教训
AI/机器学习
支付方愿意为便利性买单的市场准入“最佳切入点” 支付方愿意为便利性买单的市场准入“最佳切入点”
Blog June 3, 2026
支付方愿意为便利性买单的市场准入“最佳切入点”
医疗保险 定价 市场准入 真实世界数据 美国市场 药政法规
2026 年值得关注的 5 大医疗技术趋势 2026 年值得关注的 5 大医疗技术趋势
Blog May 28, 2026
2026 年值得关注的 5 大医疗技术趋势
AI/机器学习 GLP-1 医疗技术 带量采购(VBP) 日间手术中心(ASC)